Dexcom (DXCM) Inventory (2010 - 2026)

Dexcom (DXCM) has 17 years of Inventory data on file, last reported at $693.6 million in Q1 2026.

• Inventory for Q1 2026 came in at $693.6 million, up 28.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $693.6 million (up 28.87% YoY), and the FY2025 annual result was $629.1 million, up 15.94% from the prior year.
• Inventory rose to $693.6 million in Q1 2026 per DXCM's latest filing, from $629.1 million in the prior quarter.
• Over five years, Inventory peaked at $693.6 million in Q1 2026 and troughed at $306.7 million in Q4 2022.
• A 5-year average of $498.2 million and a median of $542.6 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2023: Inventory decreased 14.16% in 2022, then soared 82.46% in 2023.
• A 5-year view of Inventory shows it stood at $306.7 million in 2022, then surged by 82.46% to $559.6 million in 2023, then slipped by 3.04% to $542.6 million in 2024, then increased by 15.94% to $629.1 million in 2025, then rose by 10.25% to $693.6 million in 2026.
• Business Quant data shows DXCM's Inventory at $693.6 million in Q1 2026, $629.1 million in Q4 2025, and $604.1 million in Q3 2025.